Skip to main content

GLUCOGENO, MAS ALLA DE SU FUNCION TRADICIONAL

SAF2014-54525-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre FUNDACIO INSTITUT DE RECERCA BIOMEDICA (BARCELONA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth.

  • Slebe Concha, Juan Felipe, 1981-
  • Rojo, Federico
  • Vinaixa, Maria
  • García-Rocha, Mar
  • Testoni, Giorgia
  • Guiu, Marc
  • Planet, Evarist
  • Samino, Sara
  • Arenas, Enrique J.
  • Beltran Marqués, Antoni
  • Rovira Guerín, Ana
  • Lluch, Ana
  • Salvatella, Xavier
  • Yanes, Oscar
  • Albanell Mestres, Joan
  • Guinovart, Joan J. (Joan Josep), 1947-
  • Gomis, Roger R.
The mechanisms that allow breast cancer (BCa) cells to metabolically sustain rapid growth are poorly understood. Here we report that BCa cells are dependent on a mechanism to supply precursors for intracellular lipid production derived from extracellular sources and that the endothelial lipase (LIPG) fulfils this function. LIPG expression allows the import of lipid precursors, thereby contributing to BCa proliferation. LIPG stands out as an essential component of the lipid metabolic adaptations that BCa cells, and not normal tissue, must undergo to support high proliferation rates. LIPG is ubiquitously and highly expressed under the control of FoxA1 or FoxA2 in all BCa subtypes. The downregulation of either LIPG or FoxA in transformed cells results in decreased proliferation and impaired synthesis of intracellular lipids., F.S., E.J.A. and G.T. are supported by the ‘La Caixa’ PhD Fellowship Program. FIS PI12/00680, PI12/01421 and PI12/01552 supported J.A., A.L. and F.R., respectively. J.A. is part of RD12/0036/0051, RD12/0036/0070 and RD12/0036/0042 and F.R. part of biobank PT13/0010/0012. J.A. is the recipient of ISCIII intensification Grant 2014SGR740, XBTC, MARBiobanc and Cellex. R.R.G. was supported by the Institució Catalana de Recerca i Estudis Avançats. Support and structural funds were provided by the BBVA Foundation, the Generalitat de Catalunya (2014 SGR 535) and the Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER funds (SAF2013-46196) to R.R.G. and (SAF2014-54525-P) to J.J.G.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Lack of glycogenin causes glycogen accumulation and muscle function impairment

  • Testoni, Giorgia
  • Duran, Jordi
  • García-Rocha, Mar
  • Vilaplana, Francisco
  • Serrano, Antonio L.
  • Sebastián, David
  • López Soldado, Iliana
  • Sullivan, Mitchell A.
  • Slebe Concha, Juan Felipe, 1981-
  • Vilaseca, Marta
  • Muñoz Cánoves, Pura, 1962-
  • Guinovart, Joan J. (Joan Josep), 1947-
Glycogenin is considered essential for glycogen synthesis, as it acts as a primer for the initiation of the polysaccharide chain. Against expectations, glycogenin-deficient mice (Gyg KO) accumulate high amounts of glycogen in striated muscle. Furthermore, this glycogen contains no covalently bound protein, thereby demonstrating that a protein primer is not strictly necessary for the synthesis of the polysaccharide in vivo. Strikingly, in spite of the higher glycogen content, Gyg KO mice showed lower resting energy expenditure and less resistance than control animals when subjected to endurance exercise. These observations can be attributed to a switch of oxidative myofibers toward glycolytic metabolism. Mice overexpressing glycogen synthase in the muscle showed similar alterations, thus indicating that this switch is caused by the excess of glycogen. These results may explain the muscular defects of GSD XV patients, who lack glycogenin-1 and show high glycogen accumulation in muscle., We wish to thank the following members of IRB Barcelona: Anna Adrover, Emma Veza, Natalia Plana, and Vanessa Hernandez for technical assistance; and Dr. Antonio Zorzano for essential reagents and advice, the histopathology, the mouse mutant, and the biostatistics/bioinformatics core facilities. Thanks also to Dr. Marina Gay for mass spectrometry advice and data analysis and Dr. Mireia Díaz-Lobo for mass spectrometry experiments. Mass spectrometry was performed at the IRB Barcelona Mass Spectrometry and Proteomics Core Facility, which actively participates in the BMBS European COST Action BM 1403 and is a member of Proteored, PRB2-ISCIII, supported by grant PRB2 (IPT13/0001 - ISCIII-SGEFI / FEDER). Thanks also to Dr. Carmen Lopez-Iglesias (University of Barcelona) for assistance with the electron microscope. G.T. is supported by the “La Caixa” PhD Fellowship Program. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). This study was supported by grants from the Spanish MINECO (BFU2011-30554-C02-00 and SAF2014-54525-P). M.A.S. was supported by an NHMRC CJ Martin Fellowship (GNT1092451). NIH grants to Velocigene at Regeneron (U01HG004085) and the CSD Consortium (U01HG004080) funded the generation of gene-targeted ES cells in the KOMP Program. None of the supporting agencies had any role in establishing the work or in writing the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Lack of glycogenin causes glycogen accumulation and muscle function impairment

  • Testoni, Giorgia
  • Duran, Jordi
  • García-Rocha, Mar
  • Vilaplana, Francisco
  • Serrano, Antonio L.
  • Sebastián, David
  • López Soldado, Iliana
  • Sullivan, Mitchell A.
  • Slebe Concha, Juan Felipe, 1981-
  • Vilaseca, Marta
  • Muñoz Cánoves, Pura, 1962-
  • Guinovart, Joan J. (Joan Josep), 1947-
Glycogenin is considered essential for glycogen synthesis, as it acts as a primer for the initiation of the polysaccharide chain. Against expectations, glycogenin-deficient mice (Gyg KO) accumulate high amounts of glycogen in striated muscle. Furthermore, this glycogen contains no covalently bound protein, thereby demonstrating that a protein primer is not strictly necessary for the synthesis of the polysaccharide in vivo. Strikingly, in spite of the higher glycogen content, Gyg KO mice showed lower resting energy expenditure and less resistance than control animals when subjected to endurance exercise. These observations can be attributed to a switch of oxidative myofibers toward glycolytic metabolism. Mice overexpressing glycogen synthase in the muscle showed similar alterations, thus indicating that this switch is caused by the excess of glycogen. These results may explain the muscular defects of GSD XV patients, who lack glycogenin-1 and show high glycogen accumulation in muscle., We wish to thank the following members of IRB Barcelona: Anna Adrover, Emma Veza, Natalia Plana, and Vanessa Hernandez for technical assistance; and Dr. Antonio Zorzano for essential reagents and advice, the histopathology, the mouse mutant, and the biostatistics/bioinformatics core facilities. Thanks also to Dr. Marina Gay for mass spectrometry advice and data analysis and Dr. Mireia Díaz-Lobo for mass spectrometry experiments. Mass spectrometry was performed at the IRB Barcelona Mass Spectrometry and Proteomics Core Facility, which actively participates in the BMBS European COST Action BM 1403 and is a member of Proteored, PRB2-ISCIII, supported by grant PRB2 (IPT13/0001 - ISCIII-SGEFI / FEDER). Thanks also to Dr. Carmen Lopez-Iglesias (University of Barcelona) for assistance with the electron microscope. G.T. is supported by the “La Caixa” PhD Fellowship Program. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). This study was supported by grants from the Spanish MINECO (BFU2011-30554-C02-00 and SAF2014-54525-P). M.A.S. was supported by an NHMRC CJ Martin Fellowship (GNT1092451). NIH grants to Velocigene at Regeneron (U01HG004085) and the CSD Consortium (U01HG004080) funded the generation of gene-targeted ES cells in the KOMP Program. None of the supporting agencies had any role in establishing the work or in writing the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth.

  • Slebe Concha, Juan Felipe, 1981-
  • Rojo, Federico
  • Vinaixa, Maria
  • García-Rocha, Mar
  • Testoni, Giorgia
  • Guiu, Marc
  • Planet, Evarist
  • Samino, Sara
  • Arenas, Enrique J.
  • Beltran Marqués, Antoni
  • Rovira Guerín, Ana
  • Lluch, Ana
  • Salvatella, Xavier
  • Yanes, Oscar
  • Albanell Mestres, Joan
  • Guinovart, Joan J. (Joan Josep), 1947-
  • Gomis, Roger R.
The mechanisms that allow breast cancer (BCa) cells to metabolically sustain rapid growth are poorly understood. Here we report that BCa cells are dependent on a mechanism to supply precursors for intracellular lipid production derived from extracellular sources and that the endothelial lipase (LIPG) fulfils this function. LIPG expression allows the import of lipid precursors, thereby contributing to BCa proliferation. LIPG stands out as an essential component of the lipid metabolic adaptations that BCa cells, and not normal tissue, must undergo to support high proliferation rates. LIPG is ubiquitously and highly expressed under the control of FoxA1 or FoxA2 in all BCa subtypes. The downregulation of either LIPG or FoxA in transformed cells results in decreased proliferation and impaired synthesis of intracellular lipids., F.S., E.J.A. and G.T. are supported by the ‘La Caixa’ PhD Fellowship Program. FIS PI12/00680, PI12/01421 and PI12/01552 supported J.A., A.L. and F.R., respectively. J.A. is part of RD12/0036/0051, RD12/0036/0070 and RD12/0036/0042 and F.R. part of biobank PT13/0010/0012. J.A. is the recipient of ISCIII intensification Grant 2014SGR740, XBTC, MARBiobanc and Cellex. R.R.G. was supported by the Institució Catalana de Recerca i Estudis Avançats. Support and structural funds were provided by the BBVA Foundation, the Generalitat de Catalunya (2014 SGR 535) and the Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER funds (SAF2013-46196) to R.R.G. and (SAF2014-54525-P) to J.J.G.